| New |
| Code |
Description |
| A9586 |
Florbetapir f18, diagnostic, per study dose, up to 10 millicuries |
| C9294 |
Injection, taliglucerase alfa, 10 units |
| C9295 |
Injection, carfilzomib, 1 mg |
| C9296 |
Injection, ziv-aflibercept, 1 mg |
| G0453 |
Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) |
| G0454 |
Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist |
| G0456 |
Negative pressure wound therapy, (e. G. Vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters |
| G0457 |
Negative pressure wound therapy, (e. G. Vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters |
| G8926 |
Spirometry test not performed or documented, reason not given |
| G8930 |
Assessment of depression severity not documented, reason not given |
| G8931 |
Assessment of depression severity not documented, reason not given |
| G8947 |
One or more neuropsychiatric symptoms |
| G8950 |
Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up documented |
| G8951 |
Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, patient not eligible/not appropriate |
| G8952 |
Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
| G8956 |
Patient receiving maintenance hemodialysis in an outpatient dialysis facility |
| G8957 |
Patient not receiving maintenance hemodialysis in an outpatient dialysis facility |
| G8967 |
Warfarin or another oral anticoagulant that is fda approved prescribed |
| G8969 |
Documentation of patient reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved (e. G. , economic, social, and/or religious impediments, noncompliance or patient refusal, other patient reasons) |
| G8971 |
Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given |
| G8973 |
Most recent hemoglobin (hgb) level < 10 g/dl |
| G8974 |
Hemoglobin level measurement not documented, reason not given |
| G8975 |
Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e. G. , patients who have non-renal etiologies of anemia [e. G. , sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons) |
| G8976 |
Most recent hemoglobin (hgb) level >= 10 g/dl |
| J0178 |
Injection, aflibercept, 1 mg |
| J0485 |
Injection, belatacept, 1 mg |
| J0716 |
Injection, centruroides immune f(ab)2, up to 120 milligrams |
| J0890 |
Injection, peginesatide, 0. 1 mg (for esrd on dialysis) |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
| J1741 |
Injection, ibuprofen, 100 mg |
| J1744 |
Injection, icatibant, 1 mg |
| J2212 |
Injection, methylnaltrexone, 0. 1 mg |
| J7178 |
Injection, human fibrinogen concentrate, 1 mg |
| J7315 |
Mitomycin, opthalmic, 0. 2 mg |
| J7527 |
Everolimus, oral, 0. 25 mg |
| J9002 |
Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg |
| J9019 |
Injection, asparaginase (erwinaze), 1,000 iu |
| J9042 |
Injection, brentuximab vedotin, 1 mg |
| L8605 |
Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies |